Abstract
AbstractMesenchymal stromal cells (MSCs) as a kind of pluripotent adult stem cell have shown great therapeutic potential in relation to many diseases in anti-inflammation and regeneration. The results of preclinical experiments and clinical trials have demonstrated that MSC-derived secretome possesses immunoregulatory and reparative abilities and that this secretome is capable of modulating innate and adaptive immunity and reprograming the metabolism of recipient cells via paracrine mechanisms. It has been recognized that MSC-derived secretome, including soluble proteins (cytokines, chemokines, growth factors, proteases), extracellular vesicles (EVs) and organelles, plays a key role in tissue repair and regeneration in bronchopulmonary dysplasia, acute respiratory distress syndrome (ARDS), bronchial asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), pulmonary arterial hypertension, and silicosis. This review summarizes the known functions of MSC-EV modulation in lung diseases, coupled with the future challenges of MSC-EVs as a new pharmaceutical agent. The identification of underlying mechanisms for MSC-EV might provide a new direction for MSC-centered treatment in lung diseases.Graphical abstract
Funder
China Scholarship Council
Anhui Province Public Welfare Technology Application Research Project
Publisher
Springer Science and Business Media LLC
Reference146 articles.
1. Forum of International Respiratory Societies. (2017). The Global Impact of Respiratory Disease – (2nd ed.). Sheffi eld: European Respiratory Society.
2. Labaki, W. W., & Han, M. L. K. (2020). Chronic respiratory diseases: A global view. The Lancet Respiratory Medicine, 8, 531–533.
3. Soriano, J. B., et al. (2020). Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the global burden of Disease study 2017. The Lancet Respiratory Medicine, 8, 585–596.
4. Matthay, M. A., Zemans, R. L., Zimmerman, G. A., et al. (2019). Acute respiratory distress syndrome. Nature Reviews Disease Primers, 5, 18. https://doi.org/10.1038/s41572-019-0069-0.
5. Burnham, E. L., Janssen, W. J., Riches, D. W. H., Moss, M., & Downey, G. P. (2014). The fibroproliferative response in acute respiratory distress syndrome: Mechanisms and clinical significance. The European Respiratory Journal, 43, 276–285.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献